What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users.
Consolidated Framework for Implementation Research
Drug checking
Fentanyl
Harm reduction
Implementation science
Overdose
Spectroscopy
Substance use
Journal
Harm reduction journal
ISSN: 1477-7517
Titre abrégé: Harm Reduct J
Pays: England
ID NLM: 101153624
Informations de publication
Date de publication:
12 05 2020
12 05 2020
Historique:
received:
18
02
2020
accepted:
28
04
2020
entrez:
14
5
2020
pubmed:
14
5
2020
medline:
13
7
2021
Statut:
epublish
Résumé
The current illicit drug overdose crisis within North America and other countries requires expanded and new responses to address unpredictable and potentially lethal substances, including fentanyl analogues, in the unregulated drug market. Community-wide drug checking is being increasingly explored as one such public health response. We explored how drug checking could be implemented as a potential harm reduction response to the overdose crisis, from the perspective of potential service users. The research was guided by the Consolidated Framework for Implementation Research (CFIR). We conducted a qualitative, pre-implementation study to inform development and implementation of drug checking services that are acceptable to people who use substances and meet their needs. University and community researchers conducted 27 in-depth interviews with potential service users at prospective drug checking sites. We inductively developed emerging themes to inform the implementation of drug checking services within the five domains of the CFIR, and identified the most relevant constructs. Implementing community drug checking faces significant challenges within the current context of criminalization and stigmatization of substance use and people who use/sell drugs, and trauma experienced by potential service users. Participants identified significant risks in accessing drug checking, and that confidential and anonymous services are critical to address these. Engaging people with lived experience in the service can help establish trust. The relative advantage of drug checking needs to outweigh risks through provision of accurate results conveyed in a respectful, non-judgemental way. Drug checking should provide knowledge relevant to using and/or selling drugs and informing one's own harm reduction. For service users, the extent to which the implementation of drug checking can respond to and mitigate the risks of being criminalized and stigmatized is critical to the acceptability and success of community drug checking. The culture and compatibility of the service, setting and staff with harm reduction principles and practices is essential.
Sections du résumé
BACKGROUND
The current illicit drug overdose crisis within North America and other countries requires expanded and new responses to address unpredictable and potentially lethal substances, including fentanyl analogues, in the unregulated drug market. Community-wide drug checking is being increasingly explored as one such public health response. We explored how drug checking could be implemented as a potential harm reduction response to the overdose crisis, from the perspective of potential service users.
METHODS
The research was guided by the Consolidated Framework for Implementation Research (CFIR). We conducted a qualitative, pre-implementation study to inform development and implementation of drug checking services that are acceptable to people who use substances and meet their needs. University and community researchers conducted 27 in-depth interviews with potential service users at prospective drug checking sites. We inductively developed emerging themes to inform the implementation of drug checking services within the five domains of the CFIR, and identified the most relevant constructs.
RESULTS
Implementing community drug checking faces significant challenges within the current context of criminalization and stigmatization of substance use and people who use/sell drugs, and trauma experienced by potential service users. Participants identified significant risks in accessing drug checking, and that confidential and anonymous services are critical to address these. Engaging people with lived experience in the service can help establish trust. The relative advantage of drug checking needs to outweigh risks through provision of accurate results conveyed in a respectful, non-judgemental way. Drug checking should provide knowledge relevant to using and/or selling drugs and informing one's own harm reduction.
CONCLUSIONS
For service users, the extent to which the implementation of drug checking can respond to and mitigate the risks of being criminalized and stigmatized is critical to the acceptability and success of community drug checking. The culture and compatibility of the service, setting and staff with harm reduction principles and practices is essential.
Identifiants
pubmed: 32398090
doi: 10.1186/s12954-020-00373-4
pii: 10.1186/s12954-020-00373-4
pmc: PMC7216532
doi:
Substances chimiques
Illicit Drugs
0
Types de publication
Evaluation Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
29Références
PLoS Med. 2019 Nov 26;16(11):e1002969
pubmed: 31770387
Soc Sci Med. 2017 Apr;178:87-94
pubmed: 28214449
Soc Sci Med. 2014 Apr;106:151-8
pubmed: 24561777
Drug Alcohol Rev. 2011 Jan;30(1):26-32
pubmed: 21219494
Drug Alcohol Rev. 2005 Jan;24(1):21-4
pubmed: 16191717
Int J Drug Policy. 2019 Dec;74:160-169
pubmed: 31610451
Drug Alcohol Rev. 2006 Nov;25(6):611-24
pubmed: 17132577
Lancet Public Health. 2019 Feb;4(2):e81-e82
pubmed: 30579840
ANS Adv Nurs Sci. 2015 Apr-Jun;38(2):121-35
pubmed: 25932819
Int J Drug Policy. 2019 Dec;74:127-135
pubmed: 31590088
J Gen Intern Med. 2002 May;17(5):327-33
pubmed: 12047728
Drug Alcohol Depend. 2014 Dec 1;145:48-68
pubmed: 25456324
Drug Alcohol Depend. 2018 Apr 1;185:248-252
pubmed: 29475198
Int J Drug Policy. 2019 Nov;73:199-207
pubmed: 31542327
J Epidemiol Community Health. 2019 May;73(5):377-378
pubmed: 30723087
Harm Reduct J. 2019 Jun 24;16(1):39
pubmed: 31234942
Implement Sci. 2016 May 17;11:72
pubmed: 27189233
Int J Drug Policy. 2019 Jun;68:46-53
pubmed: 30991301
Can J Public Health. 2018 Dec;109(5-6):740-744
pubmed: 30251119
Drug Alcohol Depend. 2007 May 11;88(2-3):188-96
pubmed: 17118578
Drug Alcohol Depend. 2019 Jan 1;194:527-532
pubmed: 30551090
Int J Drug Policy. 2020 Mar;77:102661
pubmed: 31951925
Subst Abuse Treat Prev Policy. 2018 May 25;13(1):20
pubmed: 29801458
Int J Drug Policy. 2009 May;20(3):193-201
pubmed: 19147339
Curr HIV/AIDS Rep. 2017 Oct;14(5):161-183
pubmed: 28875422
Educ Health (Abingdon). 2001;14(2):182-97
pubmed: 14742017
Health Promot Pract. 2006 Jul;7(3):312-23
pubmed: 16760238
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Int J Drug Policy. 2016 Apr;30:17-26
pubmed: 26905934
Int J Drug Policy. 2019 Sep;71:125-132
pubmed: 31336258
Health Promot Chronic Dis Prev Can. 2018 Jun;38(6):224-233
pubmed: 29911818
Int J Drug Policy. 2019 May;67:102-107
pubmed: 30541674
Harm Reduct J. 2018 Sep 10;15(1):46
pubmed: 30200991
Int J Drug Policy. 2019 Jan;63:122-128
pubmed: 30292493
Drug Alcohol Depend. 2018 Sep 1;190:242-245
pubmed: 30064061
Int J Drug Policy. 2013 May;24(3):257-64
pubmed: 23036653
Harm Reduct J. 2020 Jan 28;17(1):9
pubmed: 32204713
Int J Drug Policy. 2019 Nov;73:88-95
pubmed: 31398488
Drug Alcohol Rev. 2018 Feb;37(2):226-236
pubmed: 28635057
Harm Reduct J. 2018 Apr 6;15(1):19
pubmed: 29625621
Br J Clin Pharmacol. 2020 Mar;86(3):420-428
pubmed: 32030770
Annu Rev Public Health. 1998;19:173-202
pubmed: 9611617
Implement Sci. 2018 Jul 26;13(1):98
pubmed: 30045735
Int J Drug Policy. 2014 Jan;25(1):34-52
pubmed: 23973009